Why BioSig Technology's Stock Is Trading Higher Friday

BioSig Technology BSGM shares are trading higher on Friday after the company's subsidiary VirtalClear submitted an investigational new drug application to the FDA for a Phase 2 clinical trial of Merimepodib.

BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology marketplace.

BioSig Technology shares were trading up 10.51% at $8.52 on Friday. The stock has a 52-week range between $9.97 and $2.36.

Related Link: Why Aptevo Therapeutics Is Trading Higher Today